Global Respiratory Inhalers Market to Grow at a CAGR of 5.40% During 2026-2035, Aided by the Increasing Prevalence of Respiratory Diseases Across the Globe

Global Respiratory Inhalers Market Overview

A respiratory inhaler is a small, handheld medical device that enables the delivery of medication directly to the lungs of the patient. Dry powder, soft mist inhalers, and metered-dose are some of the common types of respiratory inhalers available in the market. The rising burden of respiratory disorders and the advancements in inhaler devices are driving the growth of the market. The shift towards environmentally friendly inhalers that have a lower carbon footprint is a significant trend poised to impact the market dynamics. Moreover, the rising introduction of smart inhalers that enhance patient adherence and the growing emphasis on improving inhaler design are likely to influence the market growth in the forecast period.

Key Findings

• COPD and asthma remain a major public health burden, with COPD prevalence estimated at 12.64% in people aged 40 and above, and more than 27 million people living with asthma in the United States, including around 4.5 million children, sustaining strong demand for respiratory inhalers.
• The industry is transitioning to low-carbon inhalers, with regulators approving pressurised metered-dose inhalers that use next-generation propellants with near-zero global warming potential, a significant shift given that pMDIs account for roughly 76% to 80% of all inhaler use and manufacturers plan to convert their portfolios by 2030.
• Smart and connected inhalers are improving adherence, with Bluetooth-enabled sensors and cloud-based platforms allowing remote monitoring, personalised treatment, and better tracking of medication use in asthma and COPD.

Global Respiratory Inhalers Market Demand Drivers

Recent data reveals that asthma is one of the most common and expensive diseases in the United States, with every 1 in 12 people affected by this respiratory condition. It is estimated that more than 27 million individuals in the United States are living with asthma. Further, asthma is reported as a leading chronic disease in children, affecting around 4.5 million children under the age of 18 years. The increasing cases of asthma and other respiratory disorders are a major market driver, contributing to the rise in the demand for respiratory inhalers.

Global Respiratory Inhalers Market Segmentation Analysis

Product Segment Represents a Significant Market Share

Based on the product, the market segmentation includes dry powder inhalers, metered dosed inhalers, soft mist inhalers, nebulizers, and jet nebulizers (ultrasonic nebulizers, and mesh nebulizers). Dry powder inhalers are breath-activated and thus release medication in a powdered form when inhaled by the patient. They generate a significant demand among asthma and chronic pulmonary obstructive disease patients due to their ease of use. The metered dose inhalers segment also holds a high market value as they are generally more affordable than other inhaler types. In addition, the well-established production and distribution networks of metered dose inhalers further support the growth of the segment.

The market report also offers insights based on type, indication, end user, and region.

Global Respiratory Inhalers Market: Competitive Landscape

• In May 2025, AstraZeneca received a world-first UK approval for Trixeo Aerosphere (marketed as Breztri in the US, China, and Japan) using a next-generation propellant with near-zero global warming potential, a 99.9% reduction versus current propellants, followed by a positive EU CHMP opinion in 2026, with applications under review in the US, China, and other countries, and plans to transition its full pMDI portfolio by 2030.
• GSK is advancing low-carbon versions of its pressurised inhalers, including a next-generation Ventolin (salbutamol) inhaler using a low-GWP propellant, with regulatory submissions underway; Ventolin is used by around 35 million patients worldwide and accounts for a large share of the company's carbon footprint.
• Other players include Novartis, Lupin, Chiesi Farmaceutici SpA, Teva Pharmaceutical Industries, OMRON, Koninklijke Philips, PARI, Boehringer Ingelheim, Glenmark Pharmaceuticals, Presspart, Rossmax International, HELTMAN Medikal, and Microlife, spanning inhaled respiratory medicines, generics, nebulisers, soft mist devices, and inhaler components.

Global Respiratory Inhalers Market Analysis by Region

North America is Anticipated to Lead the Market Share

The market report offers an insight into various geographical locations, including North America, Europe, Asia Pacific, Latin America along with Middle East and Africa. North America dominates the market share due to the high prevalence rates of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions in the region. The presence of an advanced healthcare system and heightened awareness about respiratory health further support market growth. Moreover, the increasing population and favorable government initiatives are poised to bolster the market expansion in the region in the forecast period.

Key Offerings of the Report

• The Expert Market Research report gives an overview of the global market for respiratory inhalers for the time span of (2019-2025) and (2026-2035).
• The report also offers historical (2019-2025) and forecast (2026-2035) market information for the product, type, indication, end-user, and region of the global market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

Expert Market Research leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790